TSS
ABCL icon

Two Sigma Securities’s AbCellera Biologics ABCL Stock Holding History

Two Sigma Securities’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,163
Closed -$35.5K – 1672
2026
Q1 		$35.5K Sell
10,163
-58,121
-85% -$209K ﹤0.01% 1305
2025
Q4 		$234K Buy
68,284
+55,239
+423% +$247K 0.03% 775
2025
Q3 		$65.6K Buy
+13,045
New +$57.5K 0.01% 956
2023
Q2 		– Sell
-11,212
Closed -$84.5K – 2721
2023
Q1 		$84.5K Buy
+11,212
New +$102K ﹤0.01% 2224

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Two Sigma Securities's ABCL Position: Q2 2026 in Review

Two Sigma Securities sold out of AbCellera Biologics (ABCL) in Q2 2026, closing a stake of 10,163 shares — an estimated $35.5K sold.

Two Sigma Securities first reported a position in ABCL in Q1 2023 and held it in 4 quarters. The position peaked at $234K in Q4 2025. 150 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Two Sigma Securities reported no remaining AbCellera Biologics position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 10,163 AbCellera Biologics shares in Q2 2026, an estimated $35.5K.
  • Two Sigma Securities first reported a position in AbCellera Biologics in Q1 2023 and held it in 4 quarters.
  • Two Sigma Securities's AbCellera Biologics position peaked at $234K in Q4 2025.
  • 150 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.